Australia is experience potentially transformative treatment for weight issues: Retatrutide. The dual agonist – acting on both GLP-1 and GIP receptors – has promising efficacy in global studies, indicating considerable decreases in BMI. While availability remains with TGA, many people struggling obesity might hoping for Retatrutide as a new sol… Read More